Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 237

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 237
---
 the Meeting;                                                                          |

| (c) | subject to the terms of this Agreement, use commercially reasonable efforts to solicit proxies in favour of the                                                                                                                   
 approval of the Arrangement Resolution and against any resolution submitted by any Shareholder that is inconsistent with the Arrangement Resolution and the completion of any of the transactions contemplated by this Agreement; |

| (d) | provide the Purchaser with copies of or access to information regarding the Meeting generated by the                         
 Company’s transfer agent or any dealer or proxy solicitation services firm, as requested from time to time by the Purchaser; |

| (e) | promptly advise the Purchaser, at such times as the Purchaser may reasonably request and at least on a daily                                                                                                                     
 basis on each of the last 10 Business Days prior to the date of the Meeting, as to the aggregate tally of the proxies (for greater certainty, specifying votes “for” and votes “against” the Arrangement Resolution) received by 
 the Company in respect of the Arrangement Resolution;                                                                                                                                                                            |

| (f) | not change the record date for Shareholders entitled to vote at the Meeting in connection with any adjournment       
 or postponement of the Meeting unless required by Law or the Interim Order, or with the Purchaser’s written consent; |

| (g) | not without the prior written consent of the Purchaser, waive the deadline for the submission of proxies by 
 Shareholders for the Meeting;                                                                               |

| (h) | promptly advise the Purchaser of any substantive written communication received from, or claims brought by (or,                                                                                                                                        
 to the knowledge of the Company, threatened to be brought by), any person in opposition to the Arrangement and/or any purported exercise or withdrawal of Dissent Rights by Shareholders and, subject to Law, cooperate and provide the Purchaser with 
 (i) an opportunity to review and comment upon in advance any written communications to be sent by or on behalf of the Company to any such person and (ii) a copy of any such written communication;                                                    |

| (i) | not settle, compromise or make any payment with respect to, or agree to settle, compromise or make any payment            
 with respect to, any exercise or purported exercise of Dissent Rights without the prior written consent of the Purchaser; |

| (j) | not waive any failure by any holder of Common Shares to timely deliver a notice of exercise of Dissent Rights,                                                                             
 make any payment or settlement offer, or agree to any payment or settlement prior